Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Molecular Cancer Research : MCR|January 31, 2020
The Th9 Axis Reduces the Oxidative Stress and Promotes the Survival of Malignant T Cells in Cutaneous T-Cell Lymphoma PatientsSushant Kumar, Bhavuk Dhamija, Soumitra Marathe, et al.
British Journal of Haematology|November 2, 2022
Phase II trial of a novel chemotherapy regimen CVEP (cyclophosphamide, vinblastine, etoposide and prednisolone) for acquired immunodeficiency syndrome (AIDS)-associated lymphomasManju Sengar, Hasmukh Jain, Tanuja Shet, et al.
Neuro-Oncology|November 9, 2013
Real-time PCR assay based on the differential expression of microRNAs and protein-coding genes for molecular classification of formalin-fixed paraffin embedded medulloblastomasRatika Kunder, Rakesh Jalali, Epari Sridhar, et al.
Indian Journal of Medical and Paediatric Oncology : Official Journal of Indian Society of Medical & Paediatric Oncology|July 10, 2014
Interobserver variation is a significant limitation in the diagnosis of Burkitt lymphomaSwapnil Ulhas Rane, Tanuja Shet, Epari Sridhar, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|February 5, 2024
A Retrospective Cohort Study to Evaluate the Outcomes of HIV-Associated High-Grade B-Cell Non-Hodgkin Lymphoma (NHL) Treated with Dose Adjusted EPOCH (+/-R) RegimenJayashree Thorat, Manju Sengar, Raajit Chanana, et al.
Radiation Oncology (London, England)|February 14, 2026
Proton versus photon radiotherapy in adults with primary brain tumors evaluating functional survival: a phase 3 randomized controlled trial study protocol (PRIDE)Archya Dasgupta, Suman Ghosh, Abhishek Chatterjee, et al.
Acta Neuropathologica Communications|April 5, 2019
Downregulation of miR-204 expression defines a highly aggressive subset of Group 3/Group 4 medulloblastomasHarish Shrikrishna Bharambe, Raikamal Paul, Pooja Panwalkar, et al.
Exploration of Targeted Anti-Tumor Therapy|January 6, 2025
Preliminary evaluation of FAPI-04-PET/CT for differentiating recurrence and post-treatment changes in high-grade gliomasIndraja D Dev, Ameya D Puranik, Venkatesh Rangarajan, et al.
Neurology India|May 1, 2024
PRRT with Lu-177 DOTATATE in Treatment-Refractory Progressive Meningioma: Initial Experience from a Tertiary-Care Neuro-Oncology CenterAmeya D Puranik, Indraja D Dev, Venkatesh Rangarajan, et al.
Nature Cancer|April 5, 2022
Outcomes of COVID-19 and risk factors in patients with cancerManju Sengar, Girish Chinnaswamy, Priya Ranganathan, et al.
Pageof 7